These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19381635)

  • 1. Disease burden of psoriatic arthritis compared to rheumatoid arthritis, Hungarian experiment.
    Brodszky V; Bálint P; Géher P; Hodinka L; Horváth G; Koó É; Péntek M; Polgár A; Seszták M; Szántó S; Ujfalussy I; Gulácsi L
    Rheumatol Int; 2009 Dec; 30(2):199-205. PubMed ID: 19381635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany.
    Huscher D; Merkesdal S; Thiele K; Zeidler H; Schneider M; Zink A;
    Ann Rheum Dis; 2006 Sep; 65(9):1175-83. PubMed ID: 16540552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Disease burden of psoriasis associated with psoriatic arthritis in Hungary].
    Rencz F; Brodszky V; Péntek M; Balogh O; Remenyik E; Szegedi A; Holló P; Kárpáti S; Jókai H; Herszényi K; Herédi E; Szántó S; Gulácsi L
    Orv Hetil; 2014 Nov; 155(48):1913-21. PubMed ID: 25417138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthcare and burden of disease in psoriatic arthritis. A comparison with rheumatoid arthritis and ankylosing spondylitis.
    Zink A; Thiele K; Huscher D; Listing J; Sieper J; Krause A; Gromnica-Ihle E; von Hinueber U; Wassenberg S; Genth E; Schneider M;
    J Rheumatol; 2006 Jan; 33(1):86-90. PubMed ID: 16395755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A multicenter cross-sectional study on the health related quality of life of patients with rheumatoid arthritis using a revised Japanese version of the arthritis impact measurement scales version 2 (AIMS 2), focusing on the medical care costs and their associative factors].
    Hashimoto A; Sato H; Nishibayahi Y; Shiino Y; Kutsuna T; Ishihara Y; Hoshi K; Fujimori J; Tsuboi S; Kondo H; Akizuki M; Moroi Y; Yoshida S
    Ryumachi; 2002 Feb; 42(1):23-39. PubMed ID: 11925904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Health related quality of life and disease burden of patients with schizophrenia in Hungary].
    Péntek M; Harangozó J; Egerházi A; Kelemen O; Gulácsi L; Baji P; Máttyássy A; Erdélyi R; Lehoczky S; Orlewska E; Vártokné Hevér N; Ferencz A; Brodszky V
    Psychiatr Hung; 2012; 27(1):4-17. PubMed ID: 22493145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease activity, quality of life and indirect costs of psoriatic arthritis in Poland.
    Kawalec P; Malinowski KP; Pilc A
    Rheumatol Int; 2016 Sep; 36(9):1223-30. PubMed ID: 27339273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Productivity Loss in Patients With Chronic Diseases: A Pooled Economic Analysis of Hungarian Cost-of-Illness Studies.
    Rashdan O; Brodszky V
    Value Health Reg Issues; 2020 Sep; 22():75-82. PubMed ID: 32798838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Socioeconomic burden of psoriatic arthritis in Hong Kong: direct and indirect costs and the influence of disease pattern.
    Zhu TY; Tam LS; Leung YY; Kwok LW; Wong KC; Yu T; Kun EW; Li EK
    J Rheumatol; 2010 Jun; 37(6):1214-20. PubMed ID: 20360186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Economic Burden of Psoriatic Arthritis and the Relationship Between Functional Status and Healthcare Costs.
    McHugh N; Maguire Á; Handel I; Tillett W; Morris J; Hawkins N; Cavill C; Korendowych E; Mughal F
    J Rheumatol; 2020 May; 47(5):701-707. PubMed ID: 31416922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Impact of disease progression on health status, quality of life and costs in rheumatoid arthritis in Hungary].
    Péntek M; Szekanecz Z; Czirják L; Poór G; Rojkovich B; Polgár A; Genti G; Kiss CG; Sándor Z; Májer I; Brodszky V; Gulácsi L
    Orv Hetil; 2008 Apr; 149(16):733-41. PubMed ID: 18426720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Societal costs of rheumatoid arthritis in Hong Kong: a prevalence-based cost-of-illness study.
    Zhu TY; Tam LS; Li EK
    Rheumatology (Oxford); 2011 Jul; 50(7):1293-301. PubMed ID: 21330341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Survey of adults living with epilepsy in Hungary: health-related quality of life and costs].
    Péntek M; Bereczki D; Gulácsi L; Mikudina B; Arányi Z; Juhos V; Baji P; Brodszky V
    Ideggyogy Sz; 2013 Jul; 66(7-8):251-61. PubMed ID: 23971356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world anti-tumor necrosis factor treatment in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: cost-effectiveness based on number needed to treat to improve health assessment questionnaire.
    Barra L; Pope JE; Payne M
    J Rheumatol; 2009 Jul; 36(7):1421-8. PubMed ID: 19487267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of disability and quality of life in rheumatoid and psoriatic arthritis.
    Sokoll KB; Helliwell PS
    J Rheumatol; 2001 Aug; 28(8):1842-6. PubMed ID: 11508587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthcare utilization and economic burden of difficult-to-treat rheumatoid arthritis: a cost-of-illness study.
    Roodenrijs NMT; Welsing PMJ; van der Goes MC; Tekstra J; Lafeber FPJG; Jacobs JWG; van Laar JM
    Rheumatology (Oxford); 2021 Oct; 60(10):4681-4690. PubMed ID: 33502493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of illness and variables associated with functional impairment in Chinese patients with psoriatic arthritis.
    Leung YY; Tam LS; Kun EW; Li EK
    Clin Exp Rheumatol; 2008; 26(5):820-6. PubMed ID: 19032814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct and indirect healthcare costs of rheumatoid arthritis patients in Turkey.
    Hamuryudan V; Direskeneli H; Ertenli I; Inanc M; Karaaslan Y; Oksel F; Ozbek S; Pay S; Terzioglu E; Balkan Tezer D; Hacibedel B; Akkoc N
    Clin Exp Rheumatol; 2016; 34(6):1033-1037. PubMed ID: 27749224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the relationship between the EQ-5D, SF-6D, HAQ and disease activity in inflammatory arthritis.
    Adams R; Walsh C; Veale D; Bresnihan B; FitzGerald O; Barry M
    Pharmacoeconomics; 2010; 28(6):477-87. PubMed ID: 20465316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost of illness and quality of life of patients with rheumatoid arthritis in South Korea.
    Lee TJ; Park BH; Son HK; Song R; Shin KC; Lee EB; Song YW
    Value Health; 2012; 15(1 Suppl):S43-9. PubMed ID: 22265066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.